National Clinical Conference

Medical Cannabis as a Substitute for Prescription Drugs

Follow Us!Share This!Evidence continues to mount that medical cannabis is a viable substitute for several types of prescription medication, including opioid painkillers, anti-anxiety drugs, and sleeping medications. In November 2017, the journal PLOS One published research results out of the New Mexico Medical Marijuana Program (“Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study“) that found “a strong correlation between enrollment in an MCP and cessation or reduction of opioid use. From a…
Read more

Cannabis Research, Continuing Education Seminar, Medical Cannabis, National Clinical Conference, Opioids and Other Prescription Drugs, Public Policy, Therapeutic Effects

Cannabis: Protecting Patients and Reducing Harm

Follow Us!Share This!FOR IMMEDIATE RELEASE Berkeley, CA—May 1, 2017– Physicians, research scientists and faculty from across the U.S. and around the globe will present the latest scientific, medical and clinical research findings May 18 – 20th at Patients Out of Time’s The Eleventh National Clinical Conference on Cannabis Therapeutics: “Cannabis: Protecting Patients and Reducing Harm.” The conference is accredited for CMEs and CEUs and will be held at the Doubletree by Hilton Berkeley Marina in Berkeley, CA. Although the initial…
Read more

California, Cannabis Industry, Cannabis Research, Continuing Education Seminar, Medical Cannabis, National Clinical Conference, Public Policy, State Laws, Therapeutic Effects

, , , , , , , , ,